Gold H. Mitchell's Insider Trades & SAST Disclosures
Gold H. Mitchell's most recent trade in Alpine Immune Sciences Inc was a trade of 2,627,157 Common Stock done . Disclosure was reported to the exchange on May 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gold H. Mitchell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | 18 May 2024 | 2,627,157 | 0 (0%) | 14% | - | Common Stock | ||
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 336,755 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 270,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 255,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 247,951 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 240,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 215,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 208,916 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 200,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 96,000 | 0 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 70,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 May 2024 | 13,245 | 96,000 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.55 per share. | 08 May 2024 | 13,245 | 109,245 (0%) | 0% | 7.6 | 100,000 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 13,245 | 336,755 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 240,000 | 240,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 96,000 | 96,000 (0%) | 0% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 74,441 | 0 | - | - | Warrant (right to buy) | |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.74 per share. | 28 Dec 2023 | 74,441 | 2,675,421 (14%) | 0% | 12.7 | 948,378 | Common Stock |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.65 per share. | 28 Dec 2023 | 48,264 | 2,627,157 (14%) | 0% | 19.7 | 948,388 | Common Stock |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 28 Dec 2023 | 1,016 | 0 (0%) | 0% | 20.0 | 20,362 | Common Stock |
| Alpine Immune Sciences Inc | Gold H. Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 1,016 | 247,951 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 28 Dec 2023 | 1,016 | 1,016 (0%) | 0% | 0.6 | 660 | Common Stock |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 22 Dec 2023 | 37,825 | 37,825 (0%) | 0% | 0.4 | 17,021 | Common Stock |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 37,825 | 2,402 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 20.43 per share. | 22 Dec 2023 | 37,825 | 0 (0%) | 0% | 20.4 | 772,595 | Common Stock |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 22 Dec 2023 | 29,573 | 0 (0%) | 0% | 20.0 | 592,717 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 22 Dec 2023 | 29,573 | 29,573 (0%) | 0% | 0.6 | 19,222 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 29,573 | 248,967 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Gold Mitchell H. | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 22 Dec 2023 | 24,486 | 0 (0%) | 0% | 20.2 | 495,217 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 22,084 | 278,540 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.65 per share. | 22 Dec 2023 | 22,084 | 24,486 (0%) | 0% | 0.7 | 14,355 | Common Stock |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 22 Dec 2023 | 2,402 | 2,402 (0%) | 0% | 0.5 | 1,081 | Common Stock |
| Alpine Immune Sciences Inc | H. Mitchell Gold | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 2,402 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell Gold H. | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 2,402 | 40,227 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell Gold H. | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 19 Dec 2023 | 2,402 | 2,402 (0%) | 0% | 0.5 | 1,081 | Common Stock |
| Alpine Immune Sciences Inc | Gold H. Mitchell | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 19 Dec 2023 | 2,402 | 0 (0%) | 0% | 20.0 | 48,064 | Common Stock |
| Alpine Immune Sciences Inc | Gold H. Mitchell | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 17.26 per share. | 08 Dec 2023 | 68,870 | 32,450 (0%) | 0% | 17.3 | 1,189,027 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell Gold H. | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 08 Dec 2023 | 32,450 | 0 (0%) | 0% | 17.3 | 561,888 | Common Stock |
| Alpine Immune Sciences Inc | Gold H. Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 08 Dec 2023 | 8,613 | 8,613 (0%) | 0% | 0.5 | 3,876 | Common Stock |
| Alpine Immune Sciences Inc | Gold H. Mitchell | Director, Executive Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 8,613 | 42,629 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell Gold H. | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 17.32 per share. | 08 Dec 2023 | 8,613 | 0 (0%) | 0% | 17.3 | 149,138 | Common Stock |
| Alpine Immune Sciences Inc | H. Gold Mitchell | Director, Executive Chairman and CEO | Sale of securities on an exchange or to another person at price $ 17.08 per share. | 08 Dec 2023 | 8,067 | 101,320 (0%) | 0% | 17.1 | 137,784 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 350,000 | 350,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 215,000 | 215,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 17 Sep 2021 | 400,000 | 2,600,980 (13%) | 2% | 9.4 | 3,760,000 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 17 Sep 2021 | 45,262 | 109,387 (0%) | 0% | 10.0 | 452,964 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Sep 2021 | 6,768 | 154,649 (0%) | 0% | 10.0 | 67,696 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 15 Sep 2021 | 3,484 | 161,417 (0%) | 0% | 10 | 34,840 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 25 Jun 2021 | 9,473 | 168,380 (0%) | 0% | 10.0 | 94,865 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 25 Jun 2021 | 3,479 | 164,901 (0%) | 0% | 10.0 | 34,792 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 19 May 2021 | 50,965 | 179,074 (0%) | 0% | 15.0 | 765,917 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 19 May 2021 | 1,221 | 177,853 (0%) | 0% | 15.0 | 18,316 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.68 per share. | 12 May 2021 | 10,000 | 240,039 (1%) | 0% | 11.7 | 116,842 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.52 per share. | 12 May 2021 | 10,000 | 230,039 (1%) | 0% | 11.5 | 115,169 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.52 per share. | 13 Apr 2021 | 10,000 | 250,039 (1%) | 0% | 10.5 | 105,200 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 13 Apr 2021 | 10,000 | 260,039 (1%) | 0% | 10.1 | 100,714 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 04 Mar 2021 | 10,000 | 280,039 (1%) | 0% | 13.0 | 130,108 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 04 Mar 2021 | 10,000 | 270,039 (1%) | 0% | 13.0 | 129,875 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.74 per share. | 01 Feb 2021 | 10,000 | 290,039 (1%) | 0% | 11.7 | 117,381 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.20 per share. | 01 Feb 2021 | 7,021 | 300,039 (1%) | 0% | 13.2 | 92,698 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 01 Feb 2021 | 2,979 | 307,060 (1%) | 0% | 12.1 | 35,968 | Common Stock |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 255,000 | 255,000 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 993,801 | 3,000,980 (16%) | 5% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 Dec 2020 | 260,528 | 321,162 (1%) | 1% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Mitchell H. Gold | Director, Executive Chairman and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share. | 30 Jun 2020 | 8,227 | 60,634 (0%) | 0% | 9.7 | 79,884 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges